Sio Gene Therapies (SIOX) Short Interest Ratio & Short Volume → Emergency: Biden's $20 Trillion Mistake Could Cost YOU! (From GoldenCrest Metals) (Ad) Free SIOX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisSocial MediaStock AnalysisSocial Media Sio Gene Therapies Short Interest DataCurrent Short Volume140,900 sharesPrevious Short Volume71,400 sharesChange Vs. Previous Month+97.34%Dollar Volume Sold Short$57,853.54Short Interest Ratio / Days to Cover0.2Last Record DateMarch 15, 2023Outstanding Shares69,560,000 sharesFloat Size53,450,000 sharesShort Percent of Float0.26%Today's Trading Volume40,400 sharesAverage Trading Volume0 sharesToday's Volume Vs. Average∞ Short Selling Sio Gene Therapies ? Sign up to receive the latest short interest report for Sio Gene Therapies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSIOX Short Interest Over TimeSIOX Days to Cover Over TimeSIOX Percentage of Float Shorted Over Time Ad GoldenCrest MetalsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.Learn More Now Sio Gene Therapies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2023140,900 shares $57,853.54 +97.3%0.3%0.2 $0.41 2/28/202371,400 shares $29,338.26 -26.2%0.1%0.1 $0.41 2/15/202396,700 shares $39,763.04 -73.7%0.2%0.1 $0.41 1/31/2023367,000 shares $163,682.00 +99.0%0.7%0.5 $0.45 1/15/2023184,400 shares $82,426.80 +9.6%0.4%0.3 $0.45 12/30/2022168,200 shares $73,167.00 +5.3%0.3%0.3 $0.44 Get the Latest News and Ratings for SIOX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sio Gene Therapies and its competitors with MarketBeat's FREE daily newsletter. 12/15/2022159,700 shares $65,301.33 +19.8%0.3%0.3 $0.41 11/30/2022133,300 shares $41,043.07 -34.6%0.3%0.5 $0.31 11/15/2022203,800 shares $62,770.40 +53.5%0.4%0.9 $0.31 10/31/2022132,800 shares $38,910.40 -60.5%0.3%0.6 $0.29 10/15/2022335,800 shares $103,090.60 +7.4%0.6%1.5 $0.31 9/30/2022312,700 shares $87,556.00 +74.2%0.6%1.5 $0.28 9/15/2022179,500 shares $61,012.05 +7.6%0.3%0.6 $0.34 8/31/2022166,800 shares $55,878.00 -15.2%0.3%0.4 $0.34 8/15/2022196,600 shares $68,082.58 +22.7%0.4%0.3 $0.35 7/31/2022160,300 shares $54,870.69 -45.1%0.3%0.2 $0.34 7/15/2022291,700 shares $109,416.67 +5.2%0.6%0.3 $0.38 6/30/2022277,400 shares $99,919.48 +15.7%0.5%0.3 $0.36 6/15/2022239,800 shares $86,328.00 +33.4%0.5%0.3 $0.36 5/31/2022179,800 shares $60,233.00 -12.2%0.3%0.3 $0.34 5/15/2022204,700 shares $57,316.00 -37.2%0.4%0.4 $0.28 4/30/2022326,100 shares $91,568.88 -5.3%0.6%0.6 $0.28 4/15/2022344,300 shares $210,023.00 -8.9%0.6%0.7 $0.61 3/31/2022378,100 shares $253,327.00 -18.7%0.7%0.8 $0.67 3/15/2022465,000 shares $261,702.00 -33.9%0.9%0.9 $0.56 2/28/2022703,600 shares $471,412.00 +26.6%1.3%1.2 $0.67 2/15/2022555,800 shares $390,505.08 -37.8%1.0%0.9 $0.70 1/31/2022893,100 shares $1.04 million +56.0%1.7%1.3 $1.17 1/15/2022572,700 shares $687,240.00 -1.8%2.0%0.9 $1.20 12/31/2021583,000 shares $752,070.00 -5.5%2.0%0.5 $1.29 12/15/2021617,200 shares $851,736.00 -9.2%2.1%0.5 $1.38 11/30/2021679,900 shares $1.08 million -29.7%2.3%0.6 $1.59 11/15/2021967,300 shares $1.81 million -23.8%3.3%0.8 $1.87 10/29/20211,270,000 shares $2.43 million +45.5%4.3%1.1 $1.91 10/15/2021872,600 shares $1.90 million -19.2%3.0%0.8 $2.18 9/30/20211,080,000 shares $2.34 million -27.0%3.7%1.6 $2.17 9/15/20211,480,000 shares $3.27 million -18.2%5.0%2.4 $2.21 8/31/20211,810,000 shares $3.91 million +33.1%6.3%2.5 $2.16 8/13/20211,360,000 shares $2.76 million +8.8%4.7%2.1 $2.03 7/30/20211,250,000 shares $2.55 million -1.6%4.3%1.9 $2.04Emergency: Biden's $20 Trillion Mistake Could Cost YOU! (Ad)The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.Learn More Now SIOX Short Interest - Frequently Asked Questions What is Sio Gene Therapies' current short interest? Short interest is the volume of Sio Gene Therapies shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 140,900 shares of SIOX short. 0.26% of Sio Gene Therapies' shares are currently sold short. Learn More on Sio Gene Therapies' current short interest. What is a good short interest percentage for Sio Gene Therapies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.26% of Sio Gene Therapies' floating shares are currently sold short. Is Sio Gene Therapies' short interest increasing or decreasing? Sio Gene Therapies saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 140,900 shares, an increase of 97.3% from the previous total of 71,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sio Gene Therapies' float size? Sio Gene Therapies currently has issued a total of 0 shares. Some of Sio Gene Therapies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sio Gene Therapies currently has a public float of 53,450,000 shares. How does Sio Gene Therapies' short interest compare to its competitors? 0.26% of Sio Gene Therapies' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Sio Gene Therapies: Context Therapeutics Inc. (0.08%), Grifols, S.A. (2.32%), LAVA Therapeutics (1.50%), Mainz Biomed (2.34%), NLS Pharmaceutics Ltd. (1.54%), Pharvaris (0.10%), American Oncology Network, Inc. (1.02%), Concord Medical Services Holdings Limited (0.06%), BioVie Inc. (3.71%), Enlivex Therapeutics Ltd. (1.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Sio Gene Therapies stock? Short selling SIOX is an investing strategy that aims to generate trading profit from Sio Gene Therapies as its price is falling. SIOX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sio Gene Therapies? A short squeeze for Sio Gene Therapies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SIOX, which in turn drives the price of the stock up even further. How often is Sio Gene Therapies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SIOX, twice per month. The most recent reporting period available is March, 15 2023. More Short Interest Resources from MarketBeat Related Companies: CNTX Short Interest Data GRFS Short Interest Data LVTX Short Interest Data MYNZ Short Interest Data NLSP Short Interest Data PHVS Short Interest Data TLSA Short Interest Data ATNFW Short Interest Data ACONW Short Interest Data AIMDW Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SIOX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry Research